Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions: rationale and design of the PRImary Stenting of Occluded Native coronary arteries III (PRISON III) study.
Suttorp MJ, Laarman GJ; PRISON III study investigators. Suttorp MJ, et al. Among authors: laarman gj. Am Heart J. 2007 Sep;154(3):432-5. doi: 10.1016/j.ahj.2007.04.041. Am Heart J. 2007. PMID: 17719285 Clinical Trial.
Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study.
Dirksen MT, Vink MA, Suttorp MJ, Tijssen JG, Patterson MS, Slagboom T, Kiemeneij F, Laarman GJ; Paclitaxel-Eluting Stent versus Conventional Stent; in Myocardial Infarction with ST-Segment Elevation (PASSION) investigators. Dirksen MT, et al. Among authors: laarman gj. EuroIntervention. 2008 May;4(1):64-70. doi: 10.4244/eijv4i1a12. EuroIntervention. 2008. PMID: 19112781 Clinical Trial.
5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
Vink MA, Dirksen MT, Suttorp MJ, Tijssen JG, van Etten J, Patterson MS, Slagboom T, Kiemeneij F, Laarman GJ. Vink MA, et al. Among authors: laarman gj. JACC Cardiovasc Interv. 2011 Jan;4(1):24-9. doi: 10.1016/j.jcin.2010.11.003. JACC Cardiovasc Interv. 2011. PMID: 21251625 Free article. Clinical Trial.
Lack of long-term clinical benefit of thrombus aspiration during primary percutaneous coronary intervention with paclitaxel-eluting stents or bare-metal stents: post-hoc analysis of the PASSION-trial.
Vink MA, Dirksen MT, Tijssen JG, Suttorp MJ, Patterson MS, van Geloven N, Ijsselmuiden AJ, Slagboom T, Kiemeneij F, Laarman GJ. Vink MA, et al. Among authors: laarman gj. Catheter Cardiovasc Interv. 2012 May 1;79(6):870-7. doi: 10.1002/ccd.23226. Epub 2011 Dec 12. Catheter Cardiovasc Interv. 2012. PMID: 21735533 Clinical Trial.
Patency of paclitaxel-eluting versus bare metal stents long term after implantation in acute ST-segment elevation myocardial infarction.
Vink MA, Van Nooijen FC, Laarman GJ, Suttorp MJ, Tijssen JG, Slagboom T, Patterson MS, Van Der Schaaf RJ, Kiemeneij F, Amoroso G, Dirksen MT. Vink MA, et al. Among authors: laarman gj. Am J Cardiol. 2011 Nov 1;108(9):1214-9. doi: 10.1016/j.amjcard.2011.06.034. Epub 2011 Aug 23. Am J Cardiol. 2011. PMID: 21864813 Clinical Trial.
109 results